Evidence map›Paper›PMID 28209748›Full record

GuidelineThe oncologist2017

The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

Ahmed Sultan, Glenn J Hanna, Danielle N Margalit, Nicole Chau, Laura A Goguen, Francisco M Marty, Guilherme Rabinowits, Jonathan D Schoenfeld, Stephen T Sonis, Tom Thomas and 6 more

Erratum issuedOpen access · bronzeAbstract readReviewPractice Guideline
In one paragraph

Guideline in The oncologist, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Management of Calvarial Osteoradionecrosis After Treatment of Cutaneous Malignancy: A Systematic Review.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Managing Mandibular Osteoradionecrosis.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Review
  8. Hyperbaric Oxygen Therapy for the Treatment of Bone-Related Diseases.International journal of molecular sciences · 2025
    Review
  9. Review
  10. Review
  11. Review
  12. Osteonecrosis of the Jaws: An Update and Review of Literature.Journal of maxillofacial and oral surgery · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Osteoradionecrosis of the jaw: A mini review.Frontiers in oral health · 2022
    Review
  19. Article
  20. Pentoxifylline, tocopherol, and sequestrectomy are effective for the management of advanced osteoradionecrosis of the jaws-a case series.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Ahmed SultanDivision of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Glenn J HannaDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Robert_haddad@dfci.harvard.edu hmawardi@partners.org
Danielle N MargalitDepartment of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Nicole ChauDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Robert_haddad@dfci.harvard.edu hmawardi@partners.org
Laura A GoguenDivision of Otolaryngology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Francisco M MartyDivision of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Guilherme RabinowitsDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Robert_haddad@dfci.harvard.edu hmawardi@partners.org
Jonathan D SchoenfeldDepartment of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Stephen T SonisDivision of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Tom ThomasDivision of Otolaryngology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Roy B TishlerDepartment of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Nathaniel S TreisterDivision of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Alessandro VillaDivision of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Sook-Bin WooDivision of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Robert HaddadDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Robert_haddad@dfci.harvard.edu hmawardi@partners.org
Hani MawardiDepartment of Diagnostic Sciences, King Abdulaziz University, Faculty of Dentistry, Jeddah, Saudi Arabia
Dana-Farber Cancer Institute · USBrigham and Women's Hospital · USHarvard University · USKing Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteoradionecrosis of the jaw (ORN) is an infrequent yet potentially devastating complication of radiation therapy to the head and neck region. Treatment options include antimicrobial therapy, local sequestrectomy, resection, and the use of hyperbaric oxygen (HBO). Published data on ORN are difficult to compare because of the lack of a universally accepted classification and staging system, and the literature on the use of HBO to either prevent or successfully manage ORN is controversial and inconclusive. Therefore, we aimed to establish a standard approach for using HBO at our institution. MATERIALS AND

methodsA literature search was conducted of articles published in the English language between January 1980 and January 2016. Retrieved articles were evaluated by two independent reviewers. Isolated case reports, abstracts, case series, review articles, and cohort studies without a control group were excluded; summary data were extracted from the remaining studies. A panel of experts from Head and Neck Oncology and Oral Medicine from the Dana-Farber Cancer Institute and Brigham and Women's Hospital reviewed the summary data and established multidisciplinary guidelines on the use of HBO for the prevention and management of ORN.

resultsSeven studies were evaluated and reviewed by the multidisciplinary panel. There was no consistent evidence in support of HBO for either the prevention or management of ORN.

conclusionBased on the available evidence and expert opinion, routine use of HBO for the prevention or management of ORN is not recommended and is rarely used at our institution.

Indexed as

Hyperbaric OxygenationHead and Neck NeoplasmsHumansJawOsteoradionecrosisTreatment OutcomeHyperbaric oxygenManagementOsteoradionecrosisPrevention

Identifiers

PMID28209748
PMCPMC5344641
OpenAlexW2588274135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.